Based on the measurements of operating efficiency obtained from Hologic's historical financial statements, Hologic is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in February. At this time, Hologic's Liabilities And Stockholders Equity is fairly stable compared to the past year. Inventory is likely to rise to about 820.4 M in 2026, whereas Short and Long Term Debt Total is likely to drop slightly above 1.9 B in 2026. Key indicators impacting Hologic's financial strength include:
The financial analysis of Hologic is a critical element in measuring its lifeblood. Investors should not minimize Hologic's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Understanding current and past Hologic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hologic's financial statements are interrelated, with each one affecting the others. For example, an increase in Hologic's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Hologic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hologic. Check Hologic's Beneish M Score to see the likelihood of Hologic's management manipulating its earnings.
Hologic Stock Summary
Hologic competes with Cooper Companies, Smith Nephew, Medpace Holdings, West Pharmaceutical, and Illumina. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people.
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
Cash flow analysis captures how much money flows into and out of Hologic. It measures of how well Hologic is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Hologic brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Hologic had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Hologic has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
Comparative valuation techniques use various fundamental indicators to help in determining Hologic's current stock value. Our valuation model uses many indicators to compare Hologic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hologic competition to find correlations between indicators driving Hologic's intrinsic value. More Info.
Hologic is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers reporting about 0.66 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hologic is roughly 1.52 . At this time, Hologic's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hologic's earnings, one of the primary drivers of an investment's value.
Hologic's Earnings Breakdown by Geography
Hologic Systematic Risk
Hologic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hologic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Hologic correlated with the market. If Beta is less than 0 Hologic generally moves in the opposite direction as compared to the market. If Hologic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hologic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hologic is generally in the same direction as the market. If Beta > 1 Hologic moves generally in the same direction as, but more than the movement of the benchmark.
Hologic Thematic Clasifications
Hologic is part of several thematic ideas from Obamacare Repeal to SRI Sustainable Growth. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Along with financial statement analysis, the daily predictive indicators of Hologic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hologic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hologic based on widely used predictive technical indicators. In general, we focus on analyzing Hologic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hologic's daily price indicators and compare them against related drivers.
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.